CDC lifts embargo on Lancet HIV study early after Reuters inadvertently breaks it
The U.S. Centers for Disease Control and Prevention (CDC) lifted the embargo early on a study appearing in The Lancet following an accidental break by Reuters.
NOTE: Due to an embargo break the following news, originally embargoed until 11:00 pm EDT on Wednesday, June 12, is now available for immediate release.
The Centers for Disease Control and Prevention today released the first evidence that daily medication used to treat HIV infection can also reduce the risk of HIV acquisition among people who inject drugs. The new data are published online in the Lancet.
This runs at the bottom of the Reuters story:
Reuters inadvertently published the attached story on Wednesday June 12 at 12.04 pm ahead of the embargo time of 11pm
As has been the case with another embargo break involving my colleagues, I won’t comment beyond what’s publicly available, given the conflict of interest. (The team I lead at Reuters Health broke one in November, I should point out.) Thanks for understanding.